Nano-X Imaging
NNOX Micro CapHealthcare · Medical Devices
Mis à jour: Aug 2, 2026, 22:14 UTC
Price Chart
Indicateurs clés
Valuation Analysis
About the Company
Nano-X Imaging en bref
Nano-X Imaging (NNOX) is currently trading at 0,85 € with a market capitalization of 59 M €. The 52-week range spans from 0,63 € to 4,29 €; the current price is 80.2% below the yearly high. Year-over-year revenue growth stands at +53.1%.
💰 Dividende
Nano-X Imaging currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Avis des analystes
3 analystes évaluent Nano-X Imaging (NNOX) au consensus : None. L'objectif de cours moyen est de 4,45 €, soit un potentiel de +423.86% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 2,60 € à 6,42 €.
Nano-X Imaging : la thèse d'investissement en détail
Nano-X Imaging (NNOX) operates in the Healthcare — specifically Medical Devices — and is headquartered in Israel. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
Le scénario haussier
Top-line momentum is unusually strong with revenue expanding 53.1% year-over-year, a pace that puts the company well above the market average and signals genuine demand traction rather than mere cyclical tailwind.
Le scénario baissier
Short interest sits at 10.38% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.
À surveiller
- The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
- The analyst consensus price target implies 423.86% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.
Thèse d'investissement : forces et faiblesses
- Forte croissance du CA de 53.1% sur un an
- Bilan solide avec faible endettement (D/E 6.05)
- –Positions vendeuses élevées (10.38%)
- –Free cash flow négatif
Aperçu technique
Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).
Profil de risque
The data points to market-like volatility, elevated short interest (10.38%).
Trading Data
Related Stocks in the Same Sector
More Santé stocks
Top peers in the same sector — ranked by market cap.
Where can I buy Nano-X Imaging?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
📊 Plutôt un fonds qu’une action isolée ? Comparatif d’ETF :
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news
